Pivotal Therapeutics (PVTTF) News Today → 8,788% Return Predicted For THIS Crypto (already up 40% in 6 months) (From Paradigm Press) (Ad) Free PVTTF Stock Alerts $0.0018 0.00 (0.00%) (As of 05/12/2023) Add Compare Share Share HeadlinesStock AnalysisHeadlinesStock AnalysisHeadlines All Sources Trusted Sources MarketBeat.com Benzinga Bloomberg MarketWatch Motley Fool NASDAQ PR Newswire Reuters Seeking Alpha The Street The Wall Street Journal Yahoo Finance Source Sentiment refers to the positivity or negativity of each headline according to our language processing algorithm. Sentiment All Sentiments Very Positive Positive Neutral Negative Very Negative SourceHeadlineBuy Rating for Viridian Therapeutics Backed by Strong Financials and Promising Drug Candidatemarkets.businessinsider.com - February 28 at 7:04 PMPivotal, the flying-car company backed by Google cofounder Larry Page, lays off 10% of staffbusinessinsider.com - February 24 at 12:53 AMPivotal Delivers Four BlackFly light eVTOLs for U.S. Air Force evaluation; Contracted for Eight Aircraftmarkets.businessinsider.com - February 22 at 9:40 AMPivotal Commware Promotes FWA Without Limits at 2024 Mobile World Congress Barcelonatmcnet.com - February 22 at 9:40 AMDCC Animal Hospital onboards Dr. Prabhakaran Palanichamy as Senior Veterinary Expertmsn.com - February 9 at 7:34 AMVertex's (VRTX) Q4 Earnings and Sales Surpass Estimatesmsn.com - February 6 at 1:10 PMGlobal Downstream Processing Market to Surpass 83.47 Billion by 2030 Driven by Rising Demand for Biopharmaceuticalsfinance.yahoo.com - February 5 at 3:43 PMVertex non-opioid painkiller shows positive results in critical late-stage trial on acute painmsn.com - January 30 at 6:05 PMViridian Therapeutics Announces Positive Clinical Data in Healthy Volunteer Study and Selects VRDN-003 as Potential Best-in-Class Subcutaneous anti-IGF-1R Program with Extended ...businesswire.com - December 18 at 8:27 AMPivotal Life Sciences Announces the Closing of $389M for Pivotal bioVenture Partners Fund IIfinance.yahoo.com - December 18 at 8:27 AMGlobal Semiconductor Industry Outlook 2024finance.yahoo.com - December 12 at 5:45 PMNuclear Medicine Market Valuation to Soar at 11.5% by 2030, Global Revenue to Exceed US$11 Bn: Fairfield Market Researchfinance.yahoo.com - December 12 at 12:43 PMPivotal Appoints Cyrus Sigari to its Board of Directorsmarkets.businessinsider.com - November 21 at 9:43 AMGlobal Neuromuscular Disease Therapeutics Market to Surge by $6.51 Billion by 2027, Driven by Novel Approvals and Screening Testsuk.finance.yahoo.com - October 25 at 7:25 PMJenaValve Trilogy heart valve meets primary endpoints in pivotal trialmsn.com - October 25 at 7:25 PMJenaValve Announces Late-Breaking Data from the ALIGN-AR Pivotal Trial Meeting Safety and Efficacy Endpointsmarkets.businessinsider.com - October 24 at 8:44 PMProtembis Announces FDA Approval of its Pivotal Investigational Device Exemption (IDE) Studyventurebeat.com - October 19 at 1:37 AMVideo Provides First Clear Views of WWII Aircraft Carriers Lost in the Pivotal Battle of Midwayusnews.com - September 30 at 8:35 AMIn the Pivotal South Carolina Primary, Republican Candidates Search for a Path Against Donald Trumpusnews.com - September 4 at 5:06 AMProtagonist Therapeutics: Evaluating Rusfertide's Potential For PVmsn.com - September 4 at 5:06 AMSVB Securities Maintains Viracta Therapeutics (VIRX) Outperform Recommendationmsn.com - August 15 at 11:40 PMViracta Therapeutics Reports Second Quarter 2023 Financial Results and Provides Business Updatemarkets.businessinsider.com - August 14 at 9:37 AMHow Does Pivotal Response Training (PRT) for Children With Autism Work?msn.com - August 9 at 11:47 AMPivotal Research Sticks to Their Buy Rating for Liberty Broadband (LBRDK)markets.businessinsider.com - August 7 at 7:25 AMSERD Therapeutics Market Recording a Promising CAGR of 17.5% from 2023-2031 | Reveals InsightAce Stuydfinance.yahoo.com - July 25 at 12:48 PMAutolus Therapeutics Presents Positive Results from Pivotal Phase 2 FELIX study in adult r/r B-ALL at ASCOfinance.yahoo.com - June 2 at 9:37 AMTravere Therapeutics Announces Positive Topline Results from Cohort 6 in the Phase 1/2 COMPOSE Study of Pegtibatinase in Classical Homocystinuriatechnews.tmcnet.com - May 31 at 7:24 AMAutolus Therapeutics to hold Analyst call to highlight data at ASCO from the Pivotal Phase 2 FELIX study of obe-cel data in adult r/r B-ALLbenzinga.com - May 22 at 9:39 AMInsiders Rewarded With AU$135k Addition To Investment As Pivotal Metals Stock Hits AU$17mhk.finance.yahoo.com - May 9 at 11:34 PMPivotal Research Remains a Buy on Dish Network (DISH)markets.businessinsider.com - May 9 at 6:33 PMPivotal Research Maintains Dish Network Corp - (DISH) Buy Recommendationmsn.com - May 9 at 6:33 PMe-therapeutics hails "pivotal year" but sees its losses widenmsn.com - May 5 at 1:54 PMPivotal Research Maintains Hold Rating for Altice USA: Here's What You Need To Knowmarkets.businessinsider.com - May 5 at 1:54 PMPivotal Therapeutics Inc. (PVTTF)finance.yahoo.com - April 23 at 5:55 PMCentury Park Portfolio Company, Pivotal Drive, Merges with Nova CPMbenzinga.com - April 19 at 11:55 PMPivotal Commware Lights Up mmWave Fixed Wireless Coverage in Atlantatmcnet.com - April 19 at 1:55 PMScottsdale-based Pivotal Group acquires Atlanta webcast companybizjournals.com - April 13 at 9:23 AMVivasure Medical Announces FDA IDE Approval to Initiate U.S. Pivotal Studybenzinga.com - March 13 at 10:32 AMPivotal Investment Corp. III to Appeal Delisting Determination by NYSEfinance.yahoo.com - March 1 at 9:27 AMNYSE to Suspend Trading Immediately in Pivotal Investment Corporation III (PICC) and Commence Delisting Proceedingsfinance.yahoo.com - March 1 at 4:24 AMPivotal Growth Partners Teams with Jeremiah's to Reach 100th Store Milestonefinance.yahoo.com - February 10 at 6:00 PMPivotal Commware Introduces New WaveScape Featurestmcnet.com - January 19 at 10:06 AMOstomyCure Announces Completion of Patient Recruitment Milestone in Pivotal TIES® Clinical Trialfinance.yahoo.com - January 18 at 11:57 PMGeneoscopy's Noninvasive Colorectal Cancer Screening Test Demonstrates High Sensitivity and Specificity in Large Pivotal Clinical Trialmarkets.businessinsider.com - January 10 at 10:24 AMG1 Therapeutics Announces Upcoming 2023 Readouts from its Phase 2 and Pivotal Phase 3 Clinical Trials of Trilaciclibbenzinga.com - January 9 at 8:11 AMVera Therapeutics Reports Topline Results Of Mid-stage Study Of Atacicept; Stock Tanks 60%markets.businessinsider.com - January 3 at 6:31 PMPivotal Research Reaffirms Their Buy Rating on Liberty Broadband (LBRDK)markets.businessinsider.com - November 8 at 9:26 AMNYSE to Suspend Trading Immediately in Warrants of Pivotal Investment Corporation III (PICC WS) and Commence Delisting Proceedingsbusinesswire.com - October 27 at 10:24 PMPivotal Analytics Releases Study Findings on Hottest Markets for ASC Investmentapnews.com - October 27 at 5:58 AMEnspectra Health Announces First Patient Enrolled in US Pivotal Studymarkets.businessinsider.com - October 25 at 1:53 PM Get Pivotal Therapeutics News Delivered to You Automatically Sign up to receive the latest news and ratings for PVTTF and its competitors with MarketBeat's FREE daily newsletter. Email Address They said crypto was dead. It went up 100X. (Ad)Bitcoin’s haters are out again. Despite the price doubling in the last six months alone… That hasn’t stopped the experts from piling on. Warren Buffett’s right-hand man Charlie Munger called crypto investors “idiots” in one of his last interviews. JPMorgan CEO Jamie Dimon, recently called Bitcoin a “pet rock” and “a hyped-up fraud.” But when it comes to cryptos, these are exactly the people you shouldn’t listen to. They’ve predicted crypto’s demise for years. There are five coins you must take a look at right away. PVTTF Media Mentions By Week PVTTF Media SentimentLearn about the media sentiment score. Each headline receives a score ranging from 2 (good news) to -2 (bad news). Our company news sentiment scores track the average news sentiment of articles about each company over the most recent 7 days in order to identify companies that are receiving positive press. PVTTF News Sentiment▼0.100.63▲Average Medical News Sentiment PVTTF News CoverageLearn about the media coverage comparison. We track news headlines from hundreds of news outlets and tag them by company. This chart compares the number of articles about this company in the last seven days compared with the average number of articles about this company on a typical week. PVTTF Articles This Week▼00▲PVTTF Articles Average Week Get Pivotal Therapeutics News Delivered to You Automatically Sign up to receive the latest news and ratings for PVTTF and its competitors with MarketBeat's FREE daily newsletter. Email Address Related Companies and Tools Related Companies: ADCT News BAYRY News IMUC News GNMSF News HYPMY News IMVIQ News ISCO News LVTX News MYNZ News Headlines Tools: Trending Media MentionsHigh Media Sentiment StocksLive News FeedMarketBeat OriginalsStock Ideas This page (OTCMKTS:PVTTF) was last updated on 3/18/2024 by MarketBeat.com Staff From Our PartnersCentral Bank Gold Heist In ProgressColonial MetalsLike Tiny Crypto Retirement FundsCrypto 101 MediaMake This $3 Trade the Instant the Opening Bell RingsMonument Traders AllianceDid you make $29,000 two days with AI options trades?Prosper Trading AcademyThe world’s greatest investmentPorter & CompanyForget AI, Imperium Is Expected to Grow 320,00% in 3 YearsBanyan Hill Publishingtop AI stock (it’s not MSFT, GOOGL, AMZN or AAPL)Traders AgencyStock-Picking AI Predicts #1 Stock of 2024Altimetry Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Pivotal Therapeutics Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Get 30 Days of MarketBeat All Access Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools: Best-in-Class Portfolio Monitoring View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio. Stock Ideas and Recommendations Get daily stock ideas from top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report. Advanced Stock Screeners and Research Tools Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis. Start Your 30-Day Free Trial Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Your Password: or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Choose a Password: Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.